A1 Pill - yellow round
Pill with imprint A1 is Yellow, Round and has been identified as Zolpidem Tartrate Extended Release 12.5 mg. It is supplied by Actavis Elizabeth LLC.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 12.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for A1
Zolpidem Tartrate Extended Release
- Imprint
- A1
- Strength
- 12.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Actavis Elizabeth LLC
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
hypromellose 2208 (4000 mPa.s),
hypromellose 2910 (5 mPa.s),
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:1),
microcrystalline cellulose,
sodium bicarbonate,
sodium lauryl sulfate,
magnesium silicate,
tartaric acid,
triethyl citrate,
titanium dioxide,
polydextrose,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-3482 (Discontinued) | Actavis Pharma, Inc. |
| 68084-0523 (Discontinued) | Amerisource Health Services |
Related images for "A1"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,061)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
Other brands
Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.